Search Results - "Borlat, Irene"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1
  2. 2
  3. 3

    Potent Anti-HIV Chemokine Analogs Direct Post-Endocytic Sorting of CCR5 by Bönsch, Claudia, Munteanu, Mihaela, Rossitto-Borlat, Irène, Fürstenberg, Alexandre, Hartley, Oliver

    Published in PloS one (29-04-2015)
    “…G protein-coupled receptors (GPCRs) are desensitized and internalized following activation. They are then subjected to post-endocytic sorting (degradation,…”
    Get full text
    Journal Article
  4. 4

    Generating Chemokine Analogs with Enhanced Pharmacological Properties Using Phage Display by Dorgham, Karim, Cerini, Fabrice, Gaertner, Hubert, Melotti, Astrid, Rossitto-Borlat, Irène, Gorochov, Guy, Hartley, Oliver

    Published in Methods in enzymology (01-01-2016)
    “…Phage display technology, which allows extremely rare ligands to be selected from libraries of variants according to user-defined selection criteria, has made…”
    Get more information
    Journal Article
  5. 5
  6. 6

    C2orf62 and TTC17 are involved in actin organization and ciliogenesis in zebrafish and human by Bontems, Franck, Fish, Richard J, Borlat, Irene, Lembo, Frédérique, Chocu, Sophie, Chalmel, Frédéric, Borg, Jean-Paul, Pineau, Charles, Neerman-Arbez, Marguerite, Bairoch, Amos, Lane, Lydie

    Published in PloS one (27-01-2014)
    “…Vertebrate genomes contain around 20,000 protein-encoding genes, of which a large fraction is still not associated with specific functions. A major task in…”
    Get full text
    Journal Article
  7. 7

    Dual display: phage selection driven by co-engagement of two targets by two different antibody fragments by Fagète, Séverine, Botas-Perez, Ledicia, Rossito-Borlat, Irène, Adea, Kenneth, Gueneau, Franck, Ravn, Ulla, Rousseau, François, Kosco-Vilbois, Marie, Fischer, Nicolas, Hartley, Oliver

    Published in Protein engineering, design and selection (01-09-2017)
    “…ABSTRACT Antibody phage display technology has supported the emergence of numerous therapeutic antibodies. The development of bispecific antibodies, a…”
    Get full text
    Journal Article
  8. 8

    Highly potent HIV inhibition: engineering a key anti-HIV structure from PSC-RANTES into MIP-1β/CCL4 by Gaertner, Hubert, Lebeau, Olivier, Borlat, Irène, Cerini, Fabrice, Dufour, Brigitte, Kuenzi, Gabriel, Melotti, Astrid, Fish, Richard J., Offord, Robin, Springael, Jean-Yves, Parmentier, Marc, Hartley, Oliver

    Published in Protein engineering, design and selection (01-02-2008)
    “…The HIV coreceptor CCR5 is a validated target for both the prevention and therapy of HIV infection. PSC-RANTES, an N-terminally modified analogue of one of the…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Potent Anti-HIV Chemokine Analogs Direct Post-Endocytic Sorting of CCR5: e0125396 by Bonsch, Claudia, Munteanu, Mihaela, Rossitto-Borlat, Irene, Fuerstenberg, Alexandre, Hartley, Oliver

    Published in PloS one (01-04-2015)
    “…G protein-coupled receptors (GPCRs) are desensitized and internalized following activation. They are then subjected to post-endocytic sorting (degradation,…”
    Get full text
    Journal Article
  11. 11

    C2orf62 and TTC17 Are Involved in Actin Organization and Ciliogenesis in Zebrafish and Human: e86476 by Bontems, Franck, Fish, Richard J, Borlat, Irene, Lembo, Frederique, Chocu, Sophie, Chalmel, Frederic, Borg, Jean-Paul, Pineau, Charles, Neerman-Arbez, Marguerite, Bairoch, Amos

    Published in PloS one (01-01-2014)
    “…Vertebrate genomes contain around 20,000 protein-encoding genes, of which a large fraction is still not associated with specific functions. A major task in…”
    Get full text
    Journal Article
  12. 12

    RB110 and RB157 antibodies recognize by ELISA specific phosphorylation patterns on CCR5 C-terminal peptides by Paolini-Bertrand, Marianne, Rossitto-Borlat, Irène, Martins, Elsa, Hartley, Oliver

    Published in Antibody Reports (09-04-2020)
    “…Recombinant antibodies RB110 and RB157 can be used in ELISA assays to specifically detect human CCR5 phosphorylated at serines 336/337 and at serine 349,…”
    Get full text
    Journal Article
  13. 13

    Highly potent HIV inhibition: engineering a key anti-HIV structure from PSC-RANTES into MIP-1 /CCL4 by Gaertner, H., Lebeau, O., Borlat, I., Cerini, F., Dufour, B., Kuenzi, G., Melotti, A., Fish, R. J., Offord, R., Springael, J.-Y., Parmentier, M., Hartley, O.

    Published in Protein engineering, design and selection (01-02-2008)
    “…The HIV coreceptor CCR5 is a validated target for both the prevention and therapy of HIV infection. PSC-RANTES, an N-terminally modified analogue of one of the…”
    Get full text
    Journal Article